Clinical Lung Cancer Volume 24 Issue 1 to 8

Clinical Lung Cancer is a bimonthly, peer-reviewed journal that serves as a valuable resource for researchers and clinicians involved in the study and management of lung cancer. This journal is dedicated to publishing original articles that cover various aspects of clinical and translational research related to lung cancer. Here are some key features of Clinical Lung Cancer:

• Focus on Lung Cancer: The primary focus of the journal is on lung cancer, one of the most common and challenging malignancies. It provides a platform for discussing critical aspects of lung cancer, including detection, diagnosis, prevention, and treatment.
• Clinical and Translational Research: Clinical Lung Cancer emphasizes the importance of bridging the gap between laboratory research and clinical practice. Articles published in the journal often encompass a wide range of topics, from fundamental scientific discoveries to their practical application in the clinic.
• Recent Scientifi The journal places a strong emphasis on recent scientific developments in the field of lung cancer. This includes research on new treatment modalities, emerging therapies, and innovative diagnostic techniques.
• Drug Sensitivity and Resistance: Authors are encouraged to submit research related to drug sensitivity and resistance in lung cancer. Understanding how lung cancer responds to different treatments is crucial for improving patient outcomes.
• Gene and Antisense Therapy: Clinical Lung Cancer welcomes articles exploring gene therapy and antisense therapy as potential strategies for the treatment of lung cancer.
• Pathology and Prognostic Indicators: Research on lung cancer pathology, molecular markers, and prognostic indicators is vital for tailoring treatment approaches to individual patients. The journal is interested in studies that advance our understanding of these aspects.
• Chemoprevention Strategies: Articles on strategies for preventing lung cancer, such as chemoprevention, are also within the scope of the journal.
• Multimodality Therapy: Lung cancer often requires a multidisciplinary approach to treatment explores research on multimodality therapy and the integration of various treatment approaches.

The journal publishes articles in the English language, making it accessible to a global audience of healthcare professionals, researchers, and scientists. Clinical Lung Cancer plays a crucial role in disseminating knowledge and promoting advancements in the field of lung cancer, ultimately benefiting patients with this challenging disease.

Volume 24, Issue 1: Pages 1-88 (January 2023)

Volume 24, Issue 2: Pages 89-184 (March 2023)

Volume 24, Issue 3: Pages 185-294 (May 2023)

Volume 24, Issue 4: Pages 295-388 (June 2023)

Volume 24, Issue 5: Pages 389-482 (July 2023)

Volume 24, Issue 6: Pages 483-572 (September 2023)

Volume 24, Issue 7: Pages 573-672 (November 2023)

Volume 24, Issue 8: Pages 673-760 (December 2023)